Abstract
AbstractTwo new series of pyrido[1′,2′:1,2]pyrimido[4,5‐e][1,3,4]thiadiazin‐5‐ol Schiff's bases (4 a‐j) and 1,3,5‐triazinylaminobenzamides (6 a‐e) as effective antibacterial agents targeting E.coli DNA gyrase were designed and synthesized. Compound 6 e was found to be the most promising antibacterial agent among the screened compounds. Further evaluation of the inhibitory activity of 6 e against E.coli DNA gyrase in the supercoiling assay revealed its potential inhibitory activity (IC50=4.86 μM) more than reference drug ciprofloxacin (IC50=4.98 μM). Comparison of molecular electrostatic potential maps between 6 e and ciprofloxacin revealed similar regions of positive and negative potentials. While docking studies illustrated the predicted binding mode of 6 e inside the active site of E.coli DNA gyrase which involved key binding interactions with the essential amino acid residues. Additional in silico computation of physicochemical parameters, ADMET and ligand efficiency indices pointed out to the potential drug‐like properties of 6 e as a lead compound for future optimization and development.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
